# Liothyronine Sodium

NDC: 39822-0151
Generic name: Liothyronine Sodium
Labeler / Manufacturer: XGen Pharmaceuticals DJB, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20050817

FDA application: ANDA076923

## Active ingredients

- LIOTHYRONINE SODIUM: 10 ug/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"39822-0151"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=39822-0151
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a8b39730-de19-497d-bde8-6594aa528403